ImportantUpdates
Borosil Scientific reported Q1FY27 consolidated Net Sales up 11.2% to ₹106.8 Cr, and EBITDA rose 50.1% to ₹8.7 Cr.
Borosil Scientific LimitedBOROSCI · Filed with the exchange
Pharma Packaging (+31.6%) and Lab Equipment (+31.4%) drove strong growth.
The company leverages new products and 'Make in India' initiatives for future expansion.
No comments yet. Be the first.